Altered APP processing in PDAPP (Val717 → Phe) transgenic mice yields extended-length Aβ peptides

Chera Esh, Lyle Patton, Walter Kalback, Tyler A. Kokjohn, John Lopez, Daniel Brune, Amanda J. Newell, Thomas Beach, Dale Schenk, Dora Games, Steven Paul, Kelly Bales, Bernardino Ghetti, Eduardo M. Castaño, Alex E. Roher

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Central to the pathology of Alzheimer's disease (AD) is the profuse accumulation of amyloid-β (Aβ) peptides in the brain of affected individuals, and several amyloid precursor protein (APP) transgenic (Tg) mice models have been created to mimic Aβ deposition. Among these, the PDAPP Tg mice carrying the familial AD APP 717 Val → Phe mutation have been widely used to test potential AD therapeutic interventions including active and passive anti-Aβ immunizations. The structure and biochemistry of the PDAPP Tg mice Aβ-related peptides were investigated using acid and detergent lysis of brain tissue, ultracentrifugation, FPLC, HPLC, enzymatic and chemical cleavage of peptides, Western blot, immunoprecipitation, and MALDI-TOF and SELDI-TOF mass spectrometry. Our experiments reveal that PDAPP mice produce a variety of C-terminally elongated Aβ peptides in addition to Aβ n-40 and Aβ n-42, as well as N-terminally truncated peptides, suggesting anomalous proteolysis of both APP and Aβ. Important alterations in the overall APP degradation also occur in this model, resulting in a striking comparative lack of CT83 and CT99 fragments, which may be inherent to the strain of mice, a generalized γ-secretase failure, or the ultimate manifestation of the overwhelming amount of expressed human transgene; these alterations are not observed in other strains of APP Tg mice or in sporadic AD. Understanding at the molecular level the nature of these important animal models will permit a better understanding of therapeutic interventions directed to prevent, delay, or reverse the ravages of sporadic AD.

Original languageEnglish
Pages (from-to)13807-13819
Number of pages13
JournalBiochemistry
Volume44
Issue number42
DOIs
StatePublished - Oct 25 2005

Fingerprint

Amyloid beta-Protein Precursor
Transgenic Mice
Alzheimer Disease
Peptides
Serum Amyloid A Protein
Processing
Amyloid
Proteolysis
Brain
Immunization
Amyloid Precursor Protein Secretases
Biochemistry
Ultracentrifugation
Matrix-Assisted Laser Desorption-Ionization Mass Spectrometry
Staphylococcal Protein A
Pathology
Transgenes
Immunoprecipitation
Detergents
Mass spectrometry

ASJC Scopus subject areas

  • Biochemistry

Cite this

Esh, C., Patton, L., Kalback, W., Kokjohn, T. A., Lopez, J., Brune, D., ... Roher, A. E. (2005). Altered APP processing in PDAPP (Val717 → Phe) transgenic mice yields extended-length Aβ peptides. Biochemistry, 44(42), 13807-13819. https://doi.org/10.1021/bi051213+

Altered APP processing in PDAPP (Val717 → Phe) transgenic mice yields extended-length Aβ peptides. / Esh, Chera; Patton, Lyle; Kalback, Walter; Kokjohn, Tyler A.; Lopez, John; Brune, Daniel; Newell, Amanda J.; Beach, Thomas; Schenk, Dale; Games, Dora; Paul, Steven; Bales, Kelly; Ghetti, Bernardino; Castaño, Eduardo M.; Roher, Alex E.

In: Biochemistry, Vol. 44, No. 42, 25.10.2005, p. 13807-13819.

Research output: Contribution to journalArticle

Esh, C, Patton, L, Kalback, W, Kokjohn, TA, Lopez, J, Brune, D, Newell, AJ, Beach, T, Schenk, D, Games, D, Paul, S, Bales, K, Ghetti, B, Castaño, EM & Roher, AE 2005, 'Altered APP processing in PDAPP (Val717 → Phe) transgenic mice yields extended-length Aβ peptides', Biochemistry, vol. 44, no. 42, pp. 13807-13819. https://doi.org/10.1021/bi051213+
Esh C, Patton L, Kalback W, Kokjohn TA, Lopez J, Brune D et al. Altered APP processing in PDAPP (Val717 → Phe) transgenic mice yields extended-length Aβ peptides. Biochemistry. 2005 Oct 25;44(42):13807-13819. https://doi.org/10.1021/bi051213+
Esh, Chera ; Patton, Lyle ; Kalback, Walter ; Kokjohn, Tyler A. ; Lopez, John ; Brune, Daniel ; Newell, Amanda J. ; Beach, Thomas ; Schenk, Dale ; Games, Dora ; Paul, Steven ; Bales, Kelly ; Ghetti, Bernardino ; Castaño, Eduardo M. ; Roher, Alex E. / Altered APP processing in PDAPP (Val717 → Phe) transgenic mice yields extended-length Aβ peptides. In: Biochemistry. 2005 ; Vol. 44, No. 42. pp. 13807-13819.
@article{3ac807b1d8e14f40a6e6f2a20d4d6cb2,
title = "Altered APP processing in PDAPP (Val717 → Phe) transgenic mice yields extended-length Aβ peptides",
abstract = "Central to the pathology of Alzheimer's disease (AD) is the profuse accumulation of amyloid-β (Aβ) peptides in the brain of affected individuals, and several amyloid precursor protein (APP) transgenic (Tg) mice models have been created to mimic Aβ deposition. Among these, the PDAPP Tg mice carrying the familial AD APP 717 Val → Phe mutation have been widely used to test potential AD therapeutic interventions including active and passive anti-Aβ immunizations. The structure and biochemistry of the PDAPP Tg mice Aβ-related peptides were investigated using acid and detergent lysis of brain tissue, ultracentrifugation, FPLC, HPLC, enzymatic and chemical cleavage of peptides, Western blot, immunoprecipitation, and MALDI-TOF and SELDI-TOF mass spectrometry. Our experiments reveal that PDAPP mice produce a variety of C-terminally elongated Aβ peptides in addition to Aβ n-40 and Aβ n-42, as well as N-terminally truncated peptides, suggesting anomalous proteolysis of both APP and Aβ. Important alterations in the overall APP degradation also occur in this model, resulting in a striking comparative lack of CT83 and CT99 fragments, which may be inherent to the strain of mice, a generalized γ-secretase failure, or the ultimate manifestation of the overwhelming amount of expressed human transgene; these alterations are not observed in other strains of APP Tg mice or in sporadic AD. Understanding at the molecular level the nature of these important animal models will permit a better understanding of therapeutic interventions directed to prevent, delay, or reverse the ravages of sporadic AD.",
author = "Chera Esh and Lyle Patton and Walter Kalback and Kokjohn, {Tyler A.} and John Lopez and Daniel Brune and Newell, {Amanda J.} and Thomas Beach and Dale Schenk and Dora Games and Steven Paul and Kelly Bales and Bernardino Ghetti and Casta{\~n}o, {Eduardo M.} and Roher, {Alex E.}",
year = "2005",
month = "10",
day = "25",
doi = "10.1021/bi051213+",
language = "English",
volume = "44",
pages = "13807--13819",
journal = "Biochemistry",
issn = "0006-2960",
publisher = "American Chemical Society",
number = "42",

}

TY - JOUR

T1 - Altered APP processing in PDAPP (Val717 → Phe) transgenic mice yields extended-length Aβ peptides

AU - Esh, Chera

AU - Patton, Lyle

AU - Kalback, Walter

AU - Kokjohn, Tyler A.

AU - Lopez, John

AU - Brune, Daniel

AU - Newell, Amanda J.

AU - Beach, Thomas

AU - Schenk, Dale

AU - Games, Dora

AU - Paul, Steven

AU - Bales, Kelly

AU - Ghetti, Bernardino

AU - Castaño, Eduardo M.

AU - Roher, Alex E.

PY - 2005/10/25

Y1 - 2005/10/25

N2 - Central to the pathology of Alzheimer's disease (AD) is the profuse accumulation of amyloid-β (Aβ) peptides in the brain of affected individuals, and several amyloid precursor protein (APP) transgenic (Tg) mice models have been created to mimic Aβ deposition. Among these, the PDAPP Tg mice carrying the familial AD APP 717 Val → Phe mutation have been widely used to test potential AD therapeutic interventions including active and passive anti-Aβ immunizations. The structure and biochemistry of the PDAPP Tg mice Aβ-related peptides were investigated using acid and detergent lysis of brain tissue, ultracentrifugation, FPLC, HPLC, enzymatic and chemical cleavage of peptides, Western blot, immunoprecipitation, and MALDI-TOF and SELDI-TOF mass spectrometry. Our experiments reveal that PDAPP mice produce a variety of C-terminally elongated Aβ peptides in addition to Aβ n-40 and Aβ n-42, as well as N-terminally truncated peptides, suggesting anomalous proteolysis of both APP and Aβ. Important alterations in the overall APP degradation also occur in this model, resulting in a striking comparative lack of CT83 and CT99 fragments, which may be inherent to the strain of mice, a generalized γ-secretase failure, or the ultimate manifestation of the overwhelming amount of expressed human transgene; these alterations are not observed in other strains of APP Tg mice or in sporadic AD. Understanding at the molecular level the nature of these important animal models will permit a better understanding of therapeutic interventions directed to prevent, delay, or reverse the ravages of sporadic AD.

AB - Central to the pathology of Alzheimer's disease (AD) is the profuse accumulation of amyloid-β (Aβ) peptides in the brain of affected individuals, and several amyloid precursor protein (APP) transgenic (Tg) mice models have been created to mimic Aβ deposition. Among these, the PDAPP Tg mice carrying the familial AD APP 717 Val → Phe mutation have been widely used to test potential AD therapeutic interventions including active and passive anti-Aβ immunizations. The structure and biochemistry of the PDAPP Tg mice Aβ-related peptides were investigated using acid and detergent lysis of brain tissue, ultracentrifugation, FPLC, HPLC, enzymatic and chemical cleavage of peptides, Western blot, immunoprecipitation, and MALDI-TOF and SELDI-TOF mass spectrometry. Our experiments reveal that PDAPP mice produce a variety of C-terminally elongated Aβ peptides in addition to Aβ n-40 and Aβ n-42, as well as N-terminally truncated peptides, suggesting anomalous proteolysis of both APP and Aβ. Important alterations in the overall APP degradation also occur in this model, resulting in a striking comparative lack of CT83 and CT99 fragments, which may be inherent to the strain of mice, a generalized γ-secretase failure, or the ultimate manifestation of the overwhelming amount of expressed human transgene; these alterations are not observed in other strains of APP Tg mice or in sporadic AD. Understanding at the molecular level the nature of these important animal models will permit a better understanding of therapeutic interventions directed to prevent, delay, or reverse the ravages of sporadic AD.

UR - http://www.scopus.com/inward/record.url?scp=27144553121&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27144553121&partnerID=8YFLogxK

U2 - 10.1021/bi051213+

DO - 10.1021/bi051213+

M3 - Article

C2 - 16229470

AN - SCOPUS:27144553121

VL - 44

SP - 13807

EP - 13819

JO - Biochemistry

JF - Biochemistry

SN - 0006-2960

IS - 42

ER -